Global Markets for Ophthalmic Devices, Diagnostics, and Surgical Equipment
May 27, 2010
Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKETS FOR OPHTHALMIC DEVICES, DIAGNOSTICS, AND SURGICAL EQUIPMENT (HLC083A) from BCC Research (www.bccresearch.com), the value of the global market for ophthalmic devices, diagnostics, and surgical equipment was an estimated $15.2 billion in 2009, but is expected to increase to more than $19 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 4.6%.
The largest segment of the market, contact lenses, is projected to increase at a CAGR of 3.3%, rising to more than $7.7 billion in 2014, after being valued at nearly $6.6 billion in 2009.
The second-largest segment, the ophthalmic surgical market, is estimated at $5.5 billion in 2009, and is expected to increase at a 5-year CAGR of 5.9% to reach more than $7.3 billion in 2014.
The ophthalmic diagnostics segment is expected to reach $4 billion in 2014, after rising at a CAGR of 5.2% from its 2009 value of nearly $3.1 billion.
The aging of the population around the world will result in a rapid increase in the 65-and-over population by 2030, a population that accounts for the highest incidence and prevalence of eye conditions and diseases. This sets the stage for increased research and development activities, speedy market approvals, and higher awareness through education. The industry is likely to experience a burst of new products and heavy competition as the ophthalmic market advances.
This report’s geographical scope is worldwide with emphasis on key markets such as the United States. It identifies products by product type and, where applicable, by disease type.
The competitive landscape of the ophthalmic market is highly aggressive in both the U.S. market and internationally. Leaders in the market strive to meet the demands of the industry and continue to invest between 7% and 15% of total sales into research-and-development efforts. Long-term success is gained by focusing on improving technology and by enhancing productivity, patient outcomes, and reducing health costs to both patients and providers.
More than 50 companies are represented in this report with significant product penetration and geographical coverage. Many companies remain competitive in niche areas of the market and maintain leading market shares in their own respective markets.

Source: BCC Research
Global Markets for Ophthalmic Devices, Diagnostics and Surgical Equipment( HLC083A )
Publish Date: May 2010
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
Recent News
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand